Back to Search
Start Over
Macrolide resistance in Legionella pneumophila: the role of LpeAB efflux pump
- Source :
- Journal of Antimicrobial Chemotherapy, Journal of Antimicrobial Chemotherapy, 2017, 72 (5), pp.1327-1333. ⟨10.1093/jac/dkw594⟩, Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2017, 72 (5), pp.1327-1333. ⟨10.1093/jac/dkw594⟩
- Publication Year :
- 2017
- Publisher :
- HAL CCSD, 2017.
-
Abstract
- International audience; Objectives: A previous study on 12 in vitro -selected azithromycin-resistant Legionella~pneumophila lineages showed that ribosomal mutations were major macrolide resistance determinants. In addition to these mechanisms that have been well described in many species, mutations upstream of lpeAB operon, homologous to acrAB in Escherichia~coli , were identified in two lineages. In this study, we investigated the role of LpeAB and of these mutations in macrolide resistance of L.~pneumophila . Methods: The role of LpeAB was studied by testing the antibiotic susceptibility of WT, deleted and complemented L.~pneumophila Paris strains. Translational fusion experiments using GFP as a reporter were conducted to investigate the consequences of the mutations observed in the upstream sequence of lpeAB operon. Results: We demonstrated the involvement of LpeAB in an efflux pump responsible for a macrolide-specific reduced susceptibility of L.~pneumophila Paris strain. Mutations in the upstream sequence of lpeAB operon were associated with an increased protein expression. Increased expression was also observed under sub-inhibitory macrolide concentrations in strains with both mutated and WT promoting regions. Conclusions: LpeAB are components of an efflux pump, which is a macrolide resistance determinant in L.~pneumophila Paris strain. Mutations observed in the upstream sequence of lpeAB operon in resistant lineages led to an overexpression of this efflux pump. Sub-inhibitory concentrations of macrolides themselves participated in upregulating this efflux and could constitute a first step in the acquisition of a high macrolide resistance level.
- Subjects :
- 0301 basic medicine
Microbiology (medical)
Operon
030106 microbiology
Drug Resistance
Drug resistance
Microbial Sensitivity Tests
Biology
Azithromycin
medicine.disease_cause
Legionella pneumophila
Microbiology
03 medical and health sciences
Bacterial Proteins
Drug Resistance, Multiple, Bacterial
medicine
Pharmacology (medical)
Gene
Escherichia coli
Pharmacology
Ribosomal
Mutation
Bacterial
Membrane Transport Proteins
Ribosomal RNA
biology.organism_classification
23S
[SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology
3. Good health
Anti-Bacterial Agents
Erythromycin
RNA, Ribosomal, 23S
Infectious Diseases
Genes
Genes, Bacterial
[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology
bacteria
RNA
[SDV.IMM]Life Sciences [q-bio]/Immunology
Efflux
Macrolides
Multiple
Subjects
Details
- Language :
- English
- ISSN :
- 03057453 and 14602091
- Database :
- OpenAIRE
- Journal :
- Journal of Antimicrobial Chemotherapy, Journal of Antimicrobial Chemotherapy, 2017, 72 (5), pp.1327-1333. ⟨10.1093/jac/dkw594⟩, Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2017, 72 (5), pp.1327-1333. ⟨10.1093/jac/dkw594⟩
- Accession number :
- edsair.doi.dedup.....553b23a385f152d6ddd9d8095de57159
- Full Text :
- https://doi.org/10.1093/jac/dkw594⟩